AnaptysBio's total assets for Q1 2025 were $422.05M, a decrease of -12.77% from the previous quarter. ANAB total liabilities were $388.03M for the fiscal quarter, a -6.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.